Skip to main content
Private deals give pharma access to patient genetic data

Pharmaceutical companies are spending millions of dollars on private deals with US hospital systems that give them access to patient genetic information that could spur innovation. Patients may like the idea of free genetic testing but not be fully aware of all of the ways their genetic data is being used, and the deals raise issues about disclosures and profits.

Full Story: